(Q42210609)

English

Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy.

scientific article published on 24 June 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

3

object named as

Beom Kyung Kim

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

2

object named as

Eun Jin Yoo

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Seung Up Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Do Young Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

language of work or name

0 references

publication date

24 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

109

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1241-1249

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Lamivudine for patients with chronic hepatitis B and advanced liver disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Surrogate end points and long-term outcome in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Chronic hepatitis B: update 2009

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

KASL Clinical Practice Guidelines: Management of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Survival model predictive accuracy and ROC curves

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Natural history and prognostic factors for chronic hepatitis type B

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Long-term outcomes in hepatitis B: the REVEAL-HBV study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Natural history of hepatitis B virus infection: an update for clinicians

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Long-term outcome of chronic hepatitis B based on histological grade and stage.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B--a prospective cohort study with paired transient elastography examinations

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Exploring the combined action of lifetime alcohol intake and chronic hepatotropic virus infections on the risk of symptomatic liver cirrhosis. Collaborative Groups for the Study of Liver Diseases in Italy.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Risk assessment of liver-related events using transient elastography in patients with chronic hepatitis B receiving entecavir

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

What are 'true normal' liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South Korea

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.157

21 January 2018

Identifiers

10.1038/AJG.2014.157

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957159%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42210609&oldid=1753060250"